Lin Donna Shu-Han, Lin Yu-Sheng, Lee Jen-Kuang, Kao Hsien-Li
Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan.
Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, 100, Taiwan.
Biol Sex Differ. 2022 Apr 27;13(1):18. doi: 10.1186/s13293-022-00427-1.
Women have been underrepresented in the literature; the effects of female sex on outcomes in patients with acute myocardial infarction (AMI) remain unclear.
This study compares the real-world outcomes of women and men with AMI who have undergone revascularization via percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG).
This is a retrospective cohort study utilizing data from the Taiwan National Health Insurance database. We identified patients who were admitted for AMI and who underwent coronary revascularization during the index admission period between January 1, 2001, and December 31, 2013. Patients were then categorized based on the treatment received into PCI and CABG groups. In-hospital and long-term outcomes were compared between women and men in each group. Interaction tests were then performed to determine whether the differences between sexes were modified by the mode of revascularization. Analyses were repeated after propensity score matching between women and men in each group to minimize possible confounders. We also conducted subgroup analyses, stratifying by the presence of diabetes mellitus, congestive heart failure, and chronic kidney disease.
We enrolled 67,534 patients who met the inclusion criteria in the analysis; 60,207 patients had undergone PCI (13,514 female and 46,693 male), while 7327 patients had received CABG (1762 female and 5565 male). Prior to matching, enrolled female patients were older on average, with more comorbidities. In-hospital and long-term outcomes were worse in women, particularly in the PCI group. After matching, the incidence of hospitalization for heart failure (HHF) was higher in women (10.4% vs 8.0%, OR 1.32, 95% CI 1.22-1.43), with fewer repeat revascularizations (28.1% vs 32.4%, OR 0.84, 95% CI 0.81-0.88). Both observations were more pronounced in the PCI group (HHF: P for interaction = 0.0496; repeat revascularization: P for interaction = 0.021).
Women presenting with AMI exhibited worse in-hospital and long-term outcomes than men, especially among women who received PCI as the initial mode of revascularization. Women who underwent PCI were more likely to be admitted for heart failure during follow-up. Possible socioeconomic inequalities or a distinct pathobiology of cardiac ischemia between sexes may underlie these results; thus, further investigation is needed.
女性在相关文献中的代表性不足;女性性别对急性心肌梗死(AMI)患者预后的影响仍不明确。
本研究比较了通过经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)进行血运重建的AMI女性和男性患者的实际预后情况。
这是一项回顾性队列研究,利用了台湾国民健康保险数据库中的数据。我们确定了在2001年1月1日至2013年12月31日索引住院期间因AMI入院并接受冠状动脉血运重建的患者。然后根据接受的治疗将患者分为PCI组和CABG组。比较了每组中女性和男性的住院及长期预后情况。随后进行交互作用检验,以确定血运重建方式是否会改变性别差异。在每组的女性和男性之间进行倾向得分匹配后重复分析,以尽量减少可能的混杂因素。我们还进行了亚组分析,按是否存在糖尿病、充血性心力衰竭和慢性肾脏病进行分层。
我们纳入了67534例符合分析纳入标准的患者;60207例患者接受了PCI(女性13514例,男性46693例),而7327例患者接受了CABG(女性1762例,男性5565例)。在匹配前,纳入的女性患者平均年龄较大,合并症更多。女性的住院及长期预后较差,尤其是在PCI组。匹配后,女性心力衰竭住院(HHF)发生率较高(10.4%对8.0%,OR 1.32,95%CI 1.22 - 1.43),再次血运重建较少(28.1%对32.4%,OR 0.84,95%CI 0.81 - 0.88)。这两种观察结果在PCI组中更为明显(HHF:交互作用P = 0.0496;再次血运重建:交互作用P = 0.021)。
患有AMI的女性患者的住院及长期预后比男性差,尤其是在接受PCI作为初始血运重建方式的女性中。接受PCI的女性在随访期间更有可能因心力衰竭入院。可能的社会经济不平等或两性之间心脏缺血独特的病理生物学机制可能是这些结果的基础;因此,需要进一步研究。